PubRank

A Uzan

Author PubWeight™ 51.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci 1983 1.31
2 Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 1983 1.25
3 Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: anatomical and subcellular distribution. Brain Res Bull 1987 1.17
4 Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation. Life Sci 1984 1.08
5 Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives). Life Sci 1981 1.04
6 Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J Neurochem 1983 1.03
7 Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J Neurosci 1989 1.03
8 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties. Neuropharmacology 1985 1.02
9 Are antihistamines sedative via a blockade of brain H1 receptors? J Pharm Pharmacol 1979 1.00
10 Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci 1983 1.00
11 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties. Neuropharmacology 1985 0.98
12 Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart. Life Sci 1985 0.98
13 Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity. Stroke 2001 0.95
14 Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytes. Life Sci 1980 0.92
15 Effect of mequitazine a non sedative antihistamine on brain H1 receptors. Life Sci 1981 0.91
16 On the regional and specific serotonin uptake inhibition by LM 5008. Life Sci 1978 0.90
17 Photoaffinity labeling of peripheral-type benzodiazepine-binding sites. Mol Pharmacol 1987 0.89
18 Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism. Life Sci 1980 0.89
19 Decrease in [3H]ouabain binding sites in heart and brain from spontaneously hypertensive rats. Experientia 1981 0.86
20 PK 11195, an antagonist of peripheral type benzodiazepine receptors, modulates Bay K8644 sensitive but not beta- or H2-receptor sensitive voltage operated calcium channels in the guinea pig heart. Life Sci 1986 0.85
21 PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog. Eur J Pharmacol 1985 0.85
22 Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice. Life Sci 1984 0.85
23 Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination. Eur J Pharmacol 1985 0.84
24 "Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization. Arch Int Pharmacodyn Ther 1983 0.84
25 Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat. Life Sci 1985 0.84
26 Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma-chain carboxy terminal peptides. Thromb Haemost 1992 0.84
27 Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats. J Neurotrauma 2000 0.83
28 Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patients. Biochem Pharmacol 1984 0.82
29 Effects of 4-(3-indolyl-alkyl)piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets. Biochem Pharmacol 1977 0.82
30 On the relationship between molecular mass and anticoagulant activity in a low molecular weight heparin (enoxaparin). Thromb Haemost 1992 0.82
31 FM24: a long lasting blocker of rat liver beta-adrenoreceptors. Biochem Pharmacol 1979 0.82
32 Partial purification and pharmacology of peripheral-type benzodiazepine receptors. J Recept Res 1987 0.81
33 [Dopaminergic receptors on lymphocytes in idiopathic Parkinson's disease (author's transl)]. Rev Neurol (Paris) 1981 0.81
34 Combination of enoxaparin and fibroblast growth factor-1 increases myocardial blood flow and capillary density after myocardial infarction in rabbits. Eur Surg Res 2005 0.81
35 Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative. Eur J Pharmacol 1986 0.80
36 Evidence of an increase in brain postsynaptic alpha 1-receptors in spontaneously hypertensive rats. J Pharm Pharmacol 1980 0.80
37 Pharmacology of peripheral type benzodiazepine receptors in the heart. Prog Clin Biol Res 1985 0.80
38 Enoxaparin reduces cerebral edemaafter photothrombotic injury in the rat. Haemostasis 1999 0.79
39 Effects of 4-(3-indolyl-alkyl) piperidine derivatives on brain 5-hydroxytryptamine turnover and on cardiac and brain noradrenaline or 5-hydroxytryptamine depletion induced by 6-hydroxydopamine, H 75/12 and 4-chloroamphetamine. Biochem Pharmacol 1977 0.79
40 Relationships between plasma corticosteroids and benzodiazepines in stress. J Pharmacol Exp Ther 1979 0.79
41 In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites. Eur J Pharmacol 1984 0.79
42 Evidence for a coupling between dopaminergic receptors and phospholipid methylation in mouse B lymphocytes. Life Sci 1981 0.79
43 Cardiac beta-adrenergic receptor: evaluation of FM 24 as a new and very slowly dissociable blocker. Life Sci 1978 0.79
44 Physiopathological significance of catalytic phospholipids in the generation of thrombin. Semin Thromb Hemost 1996 0.79
45 The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog. Cardiovasc Res 1998 0.79
46 [Comparative study of absorption and distribution of quinidine arabogalactane sulfate and quinidine sulfate]. Pathol Biol (Paris) 1974 0.78
47 Selective labelling of murine B lymphocytes by [3H]spiroperidol. J Pharm Pharmacol 1981 0.78
48 Circadian rhythm in peripheral type benzodiazepine binding sites in human platelets. Biochem Pharmacol 1986 0.78
49 A subacute treatment of L-methionine induces an increase in the number of [3H]spiperone binding sites in the striatum of the rat. Life Sci 1983 0.77
50 Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, RO5-4864, of the peripheral benzodiazepine receptors. Life Sci 1984 0.77
51 Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195. Brain Res Bull 1984 0.77
52 Quantitative autoradiography of [3H]indalpine binding sites in the rat brain: II. Regional distribution. J Neurochem 1985 0.77
53 Binding in vitro of pipequaline (45319 RP) onto plasma proteins and blood cells in man. Biochem Pharmacol 1987 0.76
54 Another link between phospholipid transmembrane migration and ABC transporter gene family, inferred from a rare inherited disorder of phosphatidylserine externalization. Biochem Biophys Res Commun 1997 0.76
55 Biochemical evidence that 2-phenyl-4[(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors. Neuropharmacology 1984 0.76
56 Quantitative autoradiography of [3H]indalpine binding sites in the rat brain: I. Pharmacological characterization. J Neurochem 1985 0.76
57 Tissue levels and displacement of in vivo labelled beta-adrenergic receptors by FM 24, an irreversible or slowly dissociable beta-blocker. Eur J Pharmacol 1980 0.76
58 [L-Methionine treatment of Parkinson's disease: preliminary results]. Rev Neurol (Paris) 1982 0.76
59 Circadian rhythm in the membrane of circulating human blood cells: microviscosity and number of benzodiazepine binding sites. A search for regulation by plasma ions, nucleosides, proteins or hormones. Chronobiol Int 1987 0.76
60 [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment. Life Sci 1983 0.76
61 [Methylation of erythrocyte membrane phospholipids: correlation with membrane viscosity. Study of normal and parkinsonian subjects]. Rev Neurol (Paris) 1984 0.75
62 Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers. Br J Haematol 1991 0.75
63 Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462. J Pharmacol Exp Ther 1989 0.75
64 [Occupation of central benzodiazepine receptors and anxiety]. Therapie 1986 0.75
65 [Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169)]. Ann Pharm Fr 1985 0.75
66 Evidence for an increase in [3H]spiperone binding in hypothalamic nuclei during the development of spontaneous hypertension in the rat. Clin Exp Hypertens A 1983 0.75
67 [Introduction. Epidemiology]. Ann Pharm Fr 2004 0.75
68 Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors. Neuropharmacology 1979 0.75
69 2-Amino-6-chloro-4-(N-methylpiperazino)pyrimidines, inhibitors of spiroperidol binding. J Med Chem 1982 0.75
70 [On the different applications of agarose, a new gelatifying substance, to biological analysis]. Pathol Biol 1965 0.75
71 Comparative distribution of two antidepressant drugs (imipramine and indalpine) in the rat as determined by analog computer simulation. Eur J Drug Metab Pharmacokinet 1979 0.75
72 [Pharmacology, an innovative factor in therapeutic research]. Ann Pharm Fr 2005 0.75
73 [Viquidil: study of its metabolism by an isotopic method. 3. Excretion and biotransformation in animals]. Arzneimittelforschung 1974 0.75
74 [Inhibition of 3', 5'-cyclic AMP phosphodiesterase in the guinea pig lung by a new anti-allergic: 10-(3-quinuclidinylmethyl) phenothiazine (LM 209)]. Arch Int Pharmacodyn Ther 1976 0.75
75 Quantitative autoradiographic determination of binding sites for a peripheral benzodiazepine ligand ([3H]PK 11195) in human iris. Fundam Clin Pharmacol 1987 0.75
76 Guinea pig blood: a model for the pharmacologic modulation of the GPIb/IX-vWF axis. Thromb Res 1996 0.75
77 Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor. Thromb Res 1993 0.75
78 Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative. Biochem Pharmacol 1985 0.75
79 [Biochemical characterization and study by quantitative autoradiography of the binding sites of indalpine, a 5-HT uptake inhibitor, in cat brain]. Encephale 1986 0.75
80 High-performance liquid chromatographic determination of indalpine, a new non-tricyclic antidepressant, in human plasma: identification and simultaneous measurement of its major plasma metabolite. J Chromatogr 1982 0.75
81 Modulation of voltage-operated, but not receptor-operated, calcium channels in the rabbit aorta by PK 11195, an antagonist of peripheral-type benzodiazepine receptors. J Cardiovasc Pharmacol 1986 0.75
82 Enoxaparin (Clexane, Lovenox), a low molecular weight heparin, enhances t-PA-induced coronary thrombus lysis in anesthetized dogs without inducing hypocoagulability. Thromb Res 1992 0.75
83 Mezilamine, a new dopamine antagonist, blocks presynaptic but stimulates postsynaptic alpha-adrenoceptors. Eur J Pharmacol 1979 0.75
84 [Viquidil: study of metabolism using the isotope method. I. Synthesis of 14C-labelled viquidil]. Arzneimittelforschung 1972 0.75
85 [Viquidil: study of metabolism using the isotope method. II. Absorption and distribution of 14C-labelled viquidil in animals]. Arzneimittelforschung 1972 0.75
86 Intravenous aspirin at reperfusion does not reduce infarct size in the dog with a residual critical stenosis. J Cardiovasc Pharmacol 1999 0.75
87 [Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S]. Ann Pharm Fr 1987 0.75
88 Detection of binding sites for spiroperidol on leukemic cells: its value for the phenotype characterization of lymphoid leukemias. Leuk Res 1983 0.75
89 Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties. Life Sci 1978 0.75
90 Serotonin: change in plasma-free level and urinary excretion after LM 5008 and reserpine. Headache 1979 0.75
91 [Proserotoninergic agents and depression (author's transl)]. Encephale 1982 0.75
92 4-Amino-6-chloro-2-piperazinopyrimidines with selective affinity for alpha 2-adrenoceptors. J Med Chem 1986 0.75
93 Aggregate formation is more strongly inhibited at high shear rates by dRGDW, a synthetic RGD-containing peptide. Arterioscler Thromb 1993 0.75
94 Plasma free 5-hydroxytryptamine (5-HT): evidence of an increase induced by LM 5008, a potent 5-HT uptake inhibitor. Life Sci 1978 0.75
95 PK 10139 and quinidine: interactions with digoxin concentrations in rats and dogs. J Pharm Pharmacol 1984 0.75
96 On the long acting gastric antisecretory activity of LM 24056 a non H2 antagonist. Life Sci 1982 0.75
97 Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462. J Pharmacol Exp Ther 1989 0.75
98 [Effect of a new cerebral vasodilator agent, viquidil, on the aggregation of blood platelets]. Arzneimittelforschung 1972 0.75
99 [Study of anabolic steroid activity using C14-alpha-amino-isobutyric acid. 1. Determination of the incorporation of C14-alpha-amino-isobutyric acid in the castrated rat]. C R Seances Soc Biol Fil 1967 0.75
100 In vivo blockade of dopaminergic receptors from different rat brain regions by classical and atypical neuroleptics. Biochem Pharmacol 1980 0.75
101 Stereospecificity of the in vitro and in vivo blockade of beta-receptors by FM 24, a slowly reversible ligand. Life Sci 1981 0.75
102 [Absorption, distribution and excretion of (quinuclidinyl-3 methyl)-10-phenothiazine (LM 209), a new antihistamine]. Xenobiotica 1976 0.75
103 1-[4-(2-ter-butyl-quinolyl)]-3-(4-piperidyl)propanol (PK 10139): a new potent and long-acting antiarrhythmic agent. J Pharmacol Exp Ther 1983 0.75
104 Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors. Arch Int Pharmacodyn Ther 1984 0.75
105 [Influence of alpha-chymotrypsin on the distribution of tritiated tetracycline in rats with an experimental granuloma]. Therapie 1966 0.75
106 3-(4-Piperidinylalkyl)indoles, selective inhibitors of neuronal 5-hydroxytryptamine uptake. J Med Chem 1980 0.75
107 [Effect of some steroids on incorporation of proline-14C into bone in the castrated rat]. Experientia 1969 0.75
108 Binding sites for a peripheral type benzodiazepine antagonist ([3H]PK 11195) in human iris. Neuropharmacology 1987 0.75
109 [Biotransformation of 10-(3-quinuclidinylmethyl)phenothiazine (LM 209), a new anti-allergy agent and the distribution and excretion of its metabolites]. Xenobiotica 1976 0.75
110 [Effects of different heterocyclics on the incorporation of 5-hydroxytryptamine and noradrenaline in a rat brain preparation]. Ann Pharm Fr 1976 0.75
111 Study of two new non-steroid anti-inflammatory drugs having a pyrazole structure (LM 22070 and LM 22102). Arch Int Pharmacodyn Ther 1979 0.75
112 The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives. Neuropharmacology 1984 0.75
113 The antithrombotic activity of viquidil, a cerebral vasodilator. Arzneimittelforschung 1979 0.75
114 [Effects of indalpin, a specific 5-HT uptake inhibitor, on the ethanol behavioral dependence and on the voluntary ethanol consumption in rat (author's transl)]. Ann Pharm Fr 1981 0.75
115 Pharmacological evidence of a possible tryptaminergic regulation of opiate receptors by using indalpine, a selective 5-HT uptake inhibitor. Neuropharmacology 1980 0.75
116 Comparative effects of heparin and PK 10169, a low molecular weight fraction, in a canine model of arterial thrombosis. Thromb Res 1985 0.75
117 Central dopaminergic neurons during development of genetic and DOCA-salt hypertension in the rat. Brain Res 1981 0.75